Founder Ellen Sigal Stays as Board Chair, President Marlene Malek Becomes Vice Chair; New Leadership Structure Designed to Continue Success and Impact for Future Washington, DC, August 18, 2016 – Friends of Cancer Research (Friends) announced today that Jeff Allen, PhD, will assume the role of President and CEO effective immediately. Friends’ founder, Ellen Sigal,…
Washington, DC, June 29, 2016 – Today, Vice President Biden is hosting the first National Cancer Moonshot Summit at Howard University. The event convenes hundreds of leaders across the health, academic, private industry, and philanthropic sectors to join together with patients, survivors, and advocates. The goal of the summit is to increase efforts and double…
Parker Institute to Progress Cancer Immunotherapy Research Friends Proud to be Launch Partner for Initiative Los Angeles, CA, April 13, 2016 – Friends of Cancer Research (Friends) is proud to be a launch partner for the new Parker Institute. Announced today, the Institute was created through…
Blue Ribbon Panel of scientific experts, cancer leaders and patient advocates will inform the direction and goals of Moonshot Washington, DC, April 4, 2016 – Dr. Ellen Sigal, chairperson and founder of Friends of Cancer Research (Friends), has been appointed to the National Cancer Institute’s (NCI)…
Act Includes Friends of Cancer Research Proposal to Create Oncology Center of Excellence at FDA Washington, DC, March 17, 2016 – Friends of Cancer Research (Friends) would like to applaud Senator Alexander and Senator Murray for introducing the FDA and NIH Workforce Authorities Modernization Act. The Act takes several steps that will ultimately enhance cutting edge medical research. At a…
Washington, DC, March 18, 2016 – Friends of Cancer Research would like to congratulate Greg Simon on being named executive director of the White House’s Cancer Moonshot Task Force. Simon, a cancer survivor himself, co-founded FasterCures, an organization dedicated to saving lives by speeding up and improving medical research. Additionally, he has worked as the Senior…
Lung-MAP Precision Medicine Trial Makes Exciting Changes, With New Science and Treatment Options for Patients Lung-MAP, the most collaborative and comprehensive lung cancer clinical trial active in the U.S., uses a targeted screening approach to match patients with promising new cancer treatments based on their genomic profile. WASHINGTON, DC – The team behind the Lung…
Senate Confirms Dr. Robert Califf as FDA Commissioner Washington, DC, February 24, 2016 – Friends of Cancer Research would like to thank the Senate for doing what is right for the country and patients by confirming Dr. Robert Califf as the new FDA Commissioner. The Senate confirmed him this afternoon. “We are at a critical…
President Obama & Vice President Biden Announce $1 Billion Jumpstart on Cancer Moonshot Initiative Includes Friends of Cancer Research Proposal to Create Oncology Center of Excellence at FDA Friends of Cancer Research (Friends) would like to applaud President Obama and Vice President Biden for their leadership and vision in launching the National Cancer Moonshot. Through…
In support of Dr. Robert Califf’s recent nomination to FDA Commissioner, Friends has joined with numerous other organizations to urge the Senate towards immediate confirmation for Dr. Califf. Full text of the letter is below. Access a PDF version HERE. Dear Chairman Alexander and Ranking Member Murray: The undersigned organizations, representing millions of patients, advocates, caregivers and health care…
